{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:14Z","timestamp":1772119514018,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10620-018-5404-x","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T02:39:31Z","timestamp":1545014371000},"page":"1110-1118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients"],"prefix":"10.1007","volume":"64","author":[{"given":"Akshay","family":"Shetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Buch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammy","family":"Saab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"5404_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ajt.14559","volume":"18","author":"WR Kim","year":"2018","unstructured":"Kim WR, Lake JR, Smith JM, et al. OPTN\/SRTR 2016 annual data report: liver. Am J Transplant. 2018;18:172\u2013253.","journal-title":"Am J Transplant"},{"key":"5404_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Teresa Arias-Loste M et al. Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69:896\u2013904.","journal-title":"J Hepatol"},{"key":"5404_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2817","author":"EB Tapper","year":"2018","unstructured":"Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study. BMJ. 2018;. https:\/\/doi.org\/10.1136\/bmj.k2817 .","journal-title":"BMJ"},{"key":"5404_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2017.03.047","volume":"153","author":"IM Jacobson","year":"2017","unstructured":"Jacobson IM, Lawitz E, Gane EJ, et al. Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic HCV infection: 2 phase 3 randomized trials. Gastroenterology. 2017;153:113\u2013122.","journal-title":"Gastroenterology"},{"key":"5404_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(95)90579-0","volume":"345","author":"JM Sanchez-Tapias","year":"1995","unstructured":"Sanchez-Tapias JM, Rodes J. Dilemmas of organ transplantation from anti-HCV-positive donors. Lancet. 1995;345:469\u2013470.","journal-title":"Lancet"},{"key":"5404_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajt.13197","volume":"15","author":"WR Kim","year":"2015","unstructured":"Kim WR, Lake JR, Smith JM, et al. OPTN\/SRTR 2013 annual data report: liver. Am J Transplant. 2015;15:1\u201328.","journal-title":"Am J Transplant"},{"key":"5404_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hep.2018.06.010","author":"LS Belli","year":"2018","unstructured":"Belli LS, Perricone G, Adam R, et al. Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry. J Hepatol. 2018;. https:\/\/doi.org\/10.1016\/j.hep.2018.06.010 .","journal-title":"J Hepatol"},{"key":"5404_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/hep.28923","volume":"65","author":"JA Flemming","year":"2017","unstructured":"Flemming JA, Kim WR, Brosgart CL, Terrault NA. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology. 2017;65:804\u2013812.","journal-title":"Hepatology"},{"key":"5404_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547\u2013555.","journal-title":"Gastroenterology"},{"key":"5404_CR10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.27222","volume":"60","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60:1767\u20131775.","journal-title":"Hepatology"},{"key":"5404_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2018.02.006","author":"O Ahmed","year":"2017","unstructured":"Ahmed O, Liu L, Gayed A, Baadh A, Patel M, Tasse J, et al. The changing face of hepatocellular carcinoma: forecasting prevalence of nonalcoholic steatohepatitis and hepatitis C cirrhosis. J Clin Exp Hepatol. 2018. https:\/\/doi.org\/10.1016\/j.jceh.2018.02.006 .","journal-title":"J Clin Exp Hepatol"},{"key":"5404_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cld.2014.05.005","volume":"18","author":"S Feng","year":"2014","unstructured":"Feng S, Lai JC. Expanded criteria donors. Clin Liver Dis. 2014;18:633\u2013649.","journal-title":"Clin Liver Dis"},{"key":"5404_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ajt.13976","volume":"17","author":"MG Bowring","year":"2017","unstructured":"Bowring MG, Kucirka LM, Massie AB, et al. Changes in utilization and discard of hepatitis C-infected donor livers in the recent era. Am J Transplant. 2017;17:519\u2013527.","journal-title":"Am J Transplant"},{"key":"5404_CR14","doi-asserted-by":"publisher","first-page":"e12982","DOI":"10.1111\/tid.12982","volume":"20","author":"AA Shaffer","year":"2018","unstructured":"Shaffer AA, Thomas AG, Bowring MG, et al. Changes in practice and perception of hepatitis C and liver transplantation: results of a national survey. Transpl Infect Dis. 2018;20:e12982.","journal-title":"Transpl Infect Dis"},{"key":"5404_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cid\/cis368","volume":"55","author":"S Kamili","year":"2012","unstructured":"Kamili S, Drobeniuc J, Araujo AC, Hayden TM. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis. 2012;55:43\u201348.","journal-title":"Clin Infect Dis"},{"key":"5404_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jama.297.7.724","volume":"297","author":"JD Scott","year":"2007","unstructured":"Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA. 2007;297:724\u2013732.","journal-title":"JAMA"},{"key":"5404_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1600-6143.2009.02992.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Morris M, Blumberg E, et al. Nucleic acid testing (NAT) of organ donors: is the \u2018best\u2019 test the right test? A consensus conference report. Am J Transplant. 2010;10:889\u2013899.","journal-title":"Am J Transplant"},{"key":"5404_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJMoa1007644","volume":"364","author":"SL Stramer","year":"2011","unstructured":"Stramer SL, Wend U, Candotti D, et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med. 2011;364:236\u2013247.","journal-title":"N Engl J Med"},{"key":"5404_CR19","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1111\/ajt.14381","volume":"17","author":"J Levitsky","year":"2017","unstructured":"Levitsky J, Formica RN, Bloom RD, et al. The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation. Am J Transplant. 2017;17:2790\u20132802.","journal-title":"Am J Transplant"},{"key":"5404_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/00007890-199804150-00011","volume":"65","author":"G Testa","year":"1998","unstructured":"Testa G, Goldstein RM, Netto G, et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation. 1998;65:925\u2013929.","journal-title":"Transplantation"},{"key":"5404_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0016-5085(99)70561-5","volume":"117","author":"HE Vargas","year":"1999","unstructured":"Vargas HE, Laskus T, Wang LF, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999;117:149\u2013153.","journal-title":"Gastroenterology"},{"key":"5404_CR22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0016-5085(99)70420-8","volume":"117","author":"M Torres","year":"1999","unstructured":"Torres M, Weppler D, Reddy KR, Tzakis A. Use of hepatitis C-infected donors for hepatitis C-positive OLT recipients. Gastroenterology. 1999;117:1253.","journal-title":"Gastroenterology"},{"key":"5404_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00000658-200109000-00012","volume":"234","author":"RM Ghobrial","year":"2001","unstructured":"Ghobrial RM, Steadman R, Gornbein J, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg. 2001;234:384\u2013394.","journal-title":"Ann Surg"},{"key":"5404_CR24","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.transproceed.2012.05.012","volume":"44","author":"E \u00c1lvaro","year":"2012","unstructured":"\u00c1lvaro E, Abradelo M, Fuertes A, et al. Liver transplantation from anti-hepatitis C virus-positive donors: our experience. Transplant Proc. 2012;44:1475\u20131478.","journal-title":"Transplant Proc"},{"key":"5404_CR25","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.transproceed.2005.06.004","volume":"37","author":"A Ricchiuti","year":"2005","unstructured":"Ricchiuti A, Brunati A, Mirabella S, Pierini A, Franchello A, Salizzoni M. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience. Transplant Proc. 2005;37:2569\u20132570.","journal-title":"Transplant Proc"},{"key":"5404_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/00007890-200202270-00018","volume":"73","author":"E Velidedeoglu","year":"2002","unstructured":"Velidedeoglu E, Desai NM, Campos L, et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation. 2002;73:582\u2013587.","journal-title":"Transplantation"},{"key":"5404_CR27","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1034\/j.1600-6143.2003.00189.x","volume":"3","author":"S Saab","year":"2003","unstructured":"Saab S, Ghobrial RM, Ibrahim AB, et al. Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. Am J Transplant. 2003;3:1167\u20131172.","journal-title":"Am J Transplant"},{"key":"5404_CR28","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/lt.20849","volume":"12","author":"AP Khapra","year":"2006","unstructured":"Khapra AP, Agarwal K, Fiel MI, et al. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV\u2009+\u2009allografts. Liver Transplant. 2006;12:1496\u20131503.","journal-title":"Liver Transplant"},{"key":"5404_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/lt.23396","volume":"18","author":"JC Lai","year":"2012","unstructured":"Lai JC, O\u2019Leary JG, Trotter JF, et al. Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transplant. 2012;18:532\u2013538.","journal-title":"Liver Transplant"},{"key":"5404_CR30","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1053\/jlts.2001.27088","volume":"7","author":"CE Marroquin","year":"2001","unstructured":"Marroquin CE, Marino G, Kuo PC, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transplant. 2001;7:762\u2013768.","journal-title":"Liver Transplant"},{"key":"5404_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.gastro.2007.06.048","volume":"133","author":"R Peek","year":"2007","unstructured":"Peek R, Reddy KR. Hepatitis C virus-infected donors in liver transplantation. Gastroenterology. 2007;133:381\u2013382.","journal-title":"Gastroenterology"},{"key":"5404_CR32","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1432-2277.2010.01092.x","volume":"23","author":"PG Northup","year":"2010","unstructured":"Northup PG, Argo CK, Nguyen DT, et al. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int. 2010;23:1038\u20131044.","journal-title":"Transpl Int"},{"key":"5404_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/TP.0b013e318219eb8f","volume":"91","author":"R Ballarin","year":"2011","unstructured":"Ballarin R, Cucchetti A, Spaggiari M, et al. Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. Transplantation. 2011;91:1265\u20131272.","journal-title":"Transplantation"},{"key":"5404_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12876-016-0551-z","volume":"16","author":"M Stepanova","year":"2016","unstructured":"Stepanova M, Sayiner M, de Avila L, Younoszai Z, Racila A, Younossi ZM. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor. BMC Gastroenterol. 2016;16:137.","journal-title":"BMC Gastroenterol"},{"key":"5404_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1432-2277.2012.01498.x","volume":"25","author":"JG O\u2019Leary","year":"2012","unstructured":"O\u2019Leary JG, Neri MA, Trotter JF, Davis GL, Klintmalm GB. Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined. Transplant Int. 2012;25:825\u2013829.","journal-title":"Transplant Int"},{"key":"5404_CR36","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/hep.510290412","volume":"29","author":"JE Everhart","year":"1999","unstructured":"Everhart JE, Wei Y, Eng H, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology. 1999;29:1220\u20131226.","journal-title":"Hepatology"},{"key":"5404_CR37","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/hep.29704","volume":"67","author":"K Bari","year":"2018","unstructured":"Bari K, Luckett K, Kaiser T, et al. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients. Hepatology. 2018;67:1673\u20131682.","journal-title":"Hepatology"},{"key":"5404_CR38","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0041-1345(00)01565-7","volume":"32","author":"T Watanabe","year":"2000","unstructured":"Watanabe T, Koyama I, Shinozuka N, et al. A case of renal transplantation received from a living donor with second-generation anti-hepatitis C virus antibody positive into an anti-hepatitis C virus antibody negative recipient. Transplant Proc. 2000;32:1593\u20131594.","journal-title":"Transplant Proc"},{"key":"5404_CR39","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1111\/ajt.12400","volume":"13","author":"JM Cruzado","year":"2013","unstructured":"Cruzado JM, Gil-Vernet S, Castellote J, Bestard O, Melilli E, Grinyo JM. Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient. Am J Transplant. 2013;13:2773\u20132774.","journal-title":"Am J Transplant"},{"key":"5404_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/tri.12427","volume":"28","author":"Y Bouatou","year":"2015","unstructured":"Bouatou Y, Negro F, Hadaya K. ABO incompatible kidney transplantation from an anti-hepatitis C virus antibody-positive RNA-negative donor into an anti-hepatitis C virus antibody-negative recipient. Transplant Int. 2015;28:127\u2013128.","journal-title":"Transplant Int"},{"key":"5404_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/TXD.0000000000000614","volume":"2","author":"K Unagami","year":"2016","unstructured":"Unagami K, Ishida H, Okumi M, et al. Assessment of 4 cases of kidney transplantation from hepatitis C virus antibody-positive and RNA-negative donors to antibody-negative recipients. Transplant Direct. 2016;2:102.","journal-title":"Transplant Direct"},{"key":"5404_CR42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/TP.0000000000002034","volume":"102","author":"N Agarwal","year":"2018","unstructured":"Agarwal N, Davis R, Gracey D, et al. Detection of hepatitis C antibodies without viral transmission in hepatitis C-negative recipients receiving kidneys from hepatitis C-positive donors treated with direct-acting antiviral therapy. Transplantation. 2018;102:121\u2013122.","journal-title":"Transplantation"},{"key":"5404_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15031","author":"M Vera de","year":"2018","unstructured":"de Vera M, Volk M, Ncuba Z, et al. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia. Am J Transplant. 2018. https:\/\/doi.org\/10.1111\/ajt.15031 .","journal-title":"Am J Transplant"},{"key":"5404_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12660","author":"AP Shah","year":"2017","unstructured":"Shah AP, Cameron A, Singh P, Frank AM, Fenkel JM. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens. Transpl Infect Dis. 2017. https:\/\/doi.org\/10.1111\/tid.12660 .","journal-title":"Transpl Infect Dis"},{"key":"5404_CR45","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M17-2871","volume":"168","author":"CM Durand","year":"2018","unstructured":"Durand CM, Bowring MG, Brown DM, et al. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial. Ann Intern Med. 2018;168:533\u2013540.","journal-title":"Ann Intern Med"},{"key":"5404_CR46","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMc1705221","volume":"376","author":"DS Goldberg","year":"2017","unstructured":"Goldberg DS, Abt PL, Blumberg EA, et al. Trial of transplantation of HCV-infected kidneys into uninfected recipients. N Engl J Med. 2017;376:2394\u20132395.","journal-title":"N Engl J Med"},{"key":"5404_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7326\/M18-0749","volume":"169","author":"PP Reese","year":"2018","unstructured":"Reese PP, Abt PL, Blumberg EA, Van Deerlin VM, Bloom RD, Potluri VS, et al. Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial. Ann Intern Med. 2018;169:273\u2013281.","journal-title":"Ann Intern Med"},{"key":"5404_CR48","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0041-1345(03)00368-3","volume":"35","author":"GS Gudmundsson","year":"2003","unstructured":"Gudmundsson GS, Malinowska K, Robinson JA, et al. Five-year follow-up of hepatitis C-naive heart transplant recipients who received hepatitis C-positive donor hearts. Transplant Proc. 2003;35:1536\u20131538.","journal-title":"Transplant Proc"},{"key":"5404_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.healun.2015.10.012","volume":"35","author":"BR Englum","year":"2016","unstructured":"Englum BR, Ganapathi AM, Speicher PJ, et al. Impact of donor and recipient hepatitis C status in lung transplantation. J Heart Lung Transplant. 2016;35:228\u2013235.","journal-title":"J Heart Lung Transplant"},{"key":"5404_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/lt.24838","volume":"24","author":"B Saberi","year":"2017","unstructured":"Saberi B, Hamilton JP, Durand CM, et al. Utilization of hepatitis C RNA-positive donor liver for transplant to hepatitis C RNA-negative recipient. Liver Transplant. 2017;24:140\u2013143.","journal-title":"Liver Transplant"},{"key":"5404_CR51","doi-asserted-by":"publisher","first-page":"e12809","DOI":"10.1111\/tid.12809","volume":"20","author":"I Campos-Varela","year":"2018","unstructured":"Campos-Varela I, Agudelo E, Sarkar M, Roberts J, Terrault N. Use of hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA negative liver transplant recipient. Transplant Infect Dis. 2018;20:e12809.","journal-title":"Transplant Infect Dis"},{"key":"5404_CR52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.sla.0000183973.49899.b1","volume":"242","author":"JF Renz","year":"2005","unstructured":"Renz JF, Kin C, Kinkhabwala M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg. 2005;242:556\u2013563. (discussion 563\u2013555).","journal-title":"Ann Surg"},{"key":"5404_CR53","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/SLA.0b013e31818a080e","volume":"248","author":"FW Selck","year":"2008","unstructured":"Selck FW, Grossman EB, Ratner LE, Renz JF. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008;248:599\u2013607.","journal-title":"Ann Surg"},{"key":"5404_CR54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.sla.0000234896.18207.fa","volume":"244","author":"AJ Tector","year":"2006","unstructured":"Tector AJ, Mangus RS, Chestovich P, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg. 2006;244:439\u2013450.","journal-title":"Ann Surg"},{"key":"5404_CR55","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","volume":"10","author":"LM Kucirka","year":"2010","unstructured":"Kucirka LM, Singer AL, Ros RL, Montgomery RA, Dagher NN, Segev DL. Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients. Am J Transplant. 2010;10:1238\u20131246.","journal-title":"Am J Transplant"},{"key":"5404_CR56","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s12072-011-9257-z","volume":"5","author":"JB Cywinski","year":"2011","unstructured":"Cywinski JB, Mascha EJ, You J, et al. Pre-transplant MELD and sodium MELD scores are poor predictors of graft failure and mortality after liver transplantation. Hepatol Int. 2011;5:841\u2013849.","journal-title":"Hepatol Int"},{"key":"5404_CR57","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1111\/j.1600-6143.2008.02400.x","volume":"8","author":"A Rana","year":"2008","unstructured":"Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008;8:2537\u20132546.","journal-title":"Am J Transplant"},{"key":"5404_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","volume":"148","author":"M Charlton","year":"2015","unstructured":"Charlton M, Gane E, Manns MP, et al. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology. 2015;148:108\u2013117.","journal-title":"Gastroenterology"},{"key":"5404_CR59","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00535-017-1310-9","volume":"52","author":"Y Ueda","year":"2017","unstructured":"Ueda Y, Ikegami T, Akamatsu N, et al. Treatment with sofosbuvir and ledipasvir without ribavirin for 12\u00a0weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience. J Gastroenterol. 2017;52:986\u2013991.","journal-title":"J Gastroenterol"},{"key":"5404_CR60","doi-asserted-by":"crossref","unstructured":"Reau N, Kwo PY, Rhee S. MAGELLAN-2: Safety and Efficacy of Glecaprevir\/Pibrentasvir in Liver or Renal Transplant Adults with Chronic Hepatitis C Genotype 1\u20136 Infection. Paper presented at: EASL International Liver Meeting, April; 2017.","DOI":"10.1016\/S0168-8278(17)30444-0"},{"key":"5404_CR61","doi-asserted-by":"publisher","first-page":"e13383","DOI":"10.1111\/ctr.13383","volume":"32","author":"S Saab","year":"2018","unstructured":"Saab S, Kardashian A, Saggi S, Choi G, Agopian V, Tong MJ. Use of hepatitis C positive grafts in hepatitis C negative liver transplant recipients is cost-effective. Clin Transplant. 2018;32:e13383.","journal-title":"Clin Transplant"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5404-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T09:30:13Z","timestamp":1662629413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5404-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["5404"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5404-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734656055.793568743","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}